Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This is a randomised, double blind, cross over clinical study in healthy human volunteers
(including pharmacokinetic [PK] sampling and laser Doppler assessment of local blood flow in
a subset of up to 6 subjects per cohort of 20) to assess the efficacy and safety of three
different topical analgesics (DCF100, TIB200 and SPR300) versus placebo and active control(s)
in a model of UV-induced inflammatory pain.